A close look at human IgG sialylation and subclass distribution after lectin fractionation - Wikidata - awgldk - TriplyDB

A close look at human IgG sialylation and subclass distribution after lectin fractionation

A close look at human IgG sialylation and subclass distribution after lectin fractionation

http://www.wikidata.org/entity/Q28255484

about

Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation Mechanisms of action of intravenous immunoglobulins.Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia.Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo.Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia.Analytical and Functional Aspects of Antibody Sialylation.Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies.Anti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) gene IgG subclasses and allotypes: from structure to effector functions.Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G Anti-aβ oligomer IgG and surface sialic acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment.Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G Glycoproteomic analysis of antibodies.Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.Sialylated immunoglobulin G can neutralize influenza virus infection through receptor mimicry Harnessing glycomics technologies: integrating structure with function for glycan characterization.Fractionation of Fab glycosylated immunoglobulin G with concanavalin A chromatography unveils new structural properties of the molecule Mutation of Y407 in the CH3 domain dramatically alters glycosylation and structure of human IgG The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute.The Emerging Importance of IgG Fab Glycosylation in Immunity.Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer's disease immunotherapy.Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors.In planta protein sialylation through overexpression of the respective mammalian pathway.Characterization of the human submandibular/sublingual saliva glycoproteome using lectin affinity chromatography coupled to multidimensional protein identification technology.Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation.Autoantibodies targeting tumor-associated antigens in metastatic cancer: Sialylated IgGs as candidate anti-inflammatory antibodies.Filariasis asymptomatically infected donors have lower levels of disialylated IgG compared to endemic normals.Profiling N-linked oligosaccharides from IgG by high-performance anion-exchange chromatography with pulsed amperometric detection.Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease.Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides, and polysaccharides.Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region.Nanoscale reversed-phase liquid chromatography-mass spectrometry of permethylated N-glycans.Variable Domain N-Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody Stability.

P2860

Q28069362-3602E52E-94A2-454A-BBD2-784D5EDC4FD0 Q28728886-D823A953-07FE-4EC8-BA70-7096E765B54F Q33389428-0A878AB5-544E-4C61-A247-9AC33415E936 Q33396115-2BCEA967-EA8B-4500-8611-7CDF7716C018 Q33399238-233FF0D0-D11E-4852-8A75-0149BBCEA7EE Q33403107-1B0D5A98-B755-43C6-AD56-33A7222F723D Q33420853-2A47DC03-ECB2-4D67-BA40-E932E98817CB Q33431066-140FB111-3774-4B59-B7F1-B828AD56EC4B Q33903461-ACE8E460-8D01-4488-BB89-F6797F97F450 Q34190158-0D0D820B-B642-4FD3-8C9C-CC6225F38374 Q34199547-312D9D7F-9752-4107-917C-81642C942B59 Q34368678-31E11F12-10D8-44A5-9447-CEF709A1210C Q34468348-6DC525E6-A2D4-4A48-828F-7BA25B1E0BF9 Q35063963-69212C31-6B69-4275-A76D-53452A47B288 Q35590968-ED9DA89D-E8C5-44D2-9553-20776E120E4B Q36339643-FF1CF083-C3EF-4477-8542-F4BEB04C0A03 Q36517187-77E35B02-EFFF-44F0-A72E-CBCE13785858 Q36554708-79EEEBB0-9323-4020-AA84-26985141A893 Q36742404-4A2DA201-3315-43D5-9493-C0BBAE414B3D Q36950893-634F1689-BB7A-4AA7-9124-21FFC51CF31E Q37085836-D2FB7154-7BE6-4593-BF54-2CF836FC6929 Q37095486-D87F17D2-6AA9-4250-B916-457373C544C5 Q37327690-5B39D2BE-D00D-45CA-9819-F7E308E9590F Q37484223-60278E42-39E4-44C4-8767-CFB687A281E1 Q37995919-F790DF09-A6A6-4BFC-B2E1-5C5C09C47033 Q38133405-7BEFBF03-94F3-46D6-A942-91D404D7D067 Q38724772-60FBC1A7-BAF5-4ABA-B484-4EC53CE8C1E5 Q39062945-F9DCFE0C-C8F9-42E0-8CEB-4A8743AD89F3 Q39160831-85C759FF-AAFA-4A5F-9327-C2887E78C920 Q40602343-9F0A60D7-5497-400A-8D6F-E4A3DE535913 Q41106612-CA825760-3BB8-4368-80B7-2FFDC6069709 Q41622831-4E7067DD-3C29-492F-B479-2B6D2154262B Q41762205-F9691577-A28F-4EAF-9412-507FC2C934FB Q43692759-3851D9CD-3CD1-425B-958E-1963217835B6 Q46608396-A9E6EFEA-46F2-403E-A360-E3A162942A43 Q47220975-4F93E99A-6198-4AFE-ACD4-702492BECF66 Q48149506-064EE512-C55A-431E-99EA-D5B79543549F Q50063710-E936BF3A-A5DD-469E-83F9-3EF66E48C798 Q50497045-B061B844-FC20-4835-B2EC-F43F841EAE8F Q55091658-4F458EA2-31DE-4C95-9FE3-CCE7E1A50B20

P2860

A close look at human IgG sialylation and subclass distribution after lectin fractionation

http://www.wikidata.org/entity/Q28255484

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A close look at human IgG sial ...... ion after lectin fractionation

@ast

A close look at human IgG sial ...... ion after lectin fractionation

@en

A close look at human IgG sial ...... ion after lectin fractionation

@nl

type

label

A close look at human IgG sial ...... ion after lectin fractionation

@ast

A close look at human IgG sial ...... ion after lectin fractionation

@en

A close look at human IgG sial ...... ion after lectin fractionation

@nl

prefLabel

A close look at human IgG sial ...... ion after lectin fractionation

@ast

A close look at human IgG sial ...... ion after lectin fractionation

@en

A close look at human IgG sial ...... ion after lectin fractionation

@nl

P1433

Q28255484-5E2318E6-C3B2-4D9E-A326-E1085E3C629F

P1476

Q28255484-7F401859-93F0-4F2D-A723-3F81007C599D

P2093

Q28255484-08B8AABF-CBCC-4357-BB73-77004F282AFB

Q28255484-51A0DEC4-AD2A-4090-AB1F-42C52D3C3807

Q28255484-5AAB0590-F7A3-481F-8975-34A52DB37AF1

Q28255484-5F321568-7C6B-492F-92DC-2EF506200244

Q28255484-73985D2B-E124-4B4C-963A-C178F2EB57FD

Q28255484-D5CCAF60-8282-4997-9871-2E6D195A5592

Q28255484-DC3F20E4-1D6C-42F5-9325-E34E0A36736D

Q28255484-E9F40F5C-22DC-4FBA-B955-A199AC9B648C

P2860

Q28255484-9FE20420-D412-487C-AD79-D5E3DFC851C9

P304

Q28255484-F102DCA4-AAD8-4A0D-87FB-16639B1AC47B

P31

Q28255484-57E7B4C1-0C7C-402D-B3B4-2F49CA969467

P3181

Q28255484-94AB1F1B-2952-4AB3-BF15-DA85C19C6C70

P356

Q28255484-7BCB264B-3850-476E-B4BA-2CDEEF5408F8

P407

Q28255484-1AA69C7D-C11A-4499-93CD-156B52F1447B

P433

Q28255484-682EBD6D-4F41-4189-A913-9360CD3DA501

P478

Q28255484-C387D584-7EE0-40C1-9C5E-3ED2B3CB85B4

P577

Q28255484-4A78C8F8-3A3A-4697-BBD4-7A6318770B6C

P698

Q28255484-1C2D79BF-55DC-45C1-9828-F3120F0A6228

P3181

P356

P1433

P1476

A close look at human IgG sial ...... ion after lectin fractionation

@en

P2093

Alfred Weber

http://www.w3.org/2001/XMLSchema#string

Friedrich Altmann

http://www.w3.org/2001/XMLSchema#string

Hans Peter Schwarz

http://www.w3.org/2001/XMLSchema#string

Hartmut J Ehrlich

http://www.w3.org/2001/XMLSchema#string

Heinz Anderle

http://www.w3.org/2001/XMLSchema#string

Johannes Stadlmann

http://www.w3.org/2001/XMLSchema#string

Martin Pabst

http://www.w3.org/2001/XMLSchema#string

Renate Kunert

http://www.w3.org/2001/XMLSchema#string

P2860

Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis.

P304

4143-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2220772

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/PMIC.200800931

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19688751

http://www.w3.org/2001/XMLSchema#string